These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6272376)

  • 1. Cholecystokinin-octapeptide suppresses stress-induced eating by inducing hyperglycemia.
    Levine AS; Morley JE
    Regul Pept; 1981 Nov; 2(6):353-7. PubMed ID: 6272376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats.
    Fekete M; Szabó A; Balázs M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(1):39-45. PubMed ID: 6282048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide.
    Kádár T; Fekete M; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(4):269-74. PubMed ID: 6291322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraventricular cholecystokinin-octapeptide produces hyperglycemia in rats.
    Morley JE; Levine AS
    Life Sci; 1981 May; 28(19):2187-90. PubMed ID: 6265724
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of beta-endorphin, thyrotropin-releasing hormone and cholecystokinin on body shaking behavior in rats.
    Itoh S; Katsuura G
    Jpn J Physiol; 1982; 32(4):667-75. PubMed ID: 6294391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
    Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraventricular cholecystokinin-octapeptide produces hypothermia in rats.
    Morley JE; Levine AS; Lindblad S
    Eur J Pharmacol; 1981 Sep; 74(2-3):249-51. PubMed ID: 6276188
    [No Abstract]   [Full Text] [Related]  

  • 8. Vagal mediation of the cholecystokinin satiety effect in rats.
    Lorenz DN; Goldman SA
    Physiol Behav; 1982 Oct; 29(4):599-604. PubMed ID: 6294698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats--pharmacological characterization of this action.
    Schick RR; Yaksh TL; Go VL
    Regul Pept; 1986 Jul; 14(4):277-91. PubMed ID: 3749526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sedative action of cholecystokinin octapeptide on behavioral excitation by thyrotropin releasing hormone and methamphetamine in the rat.
    Katsuura G; Itoh S
    Jpn J Physiol; 1982; 32(1):83-91. PubMed ID: 6281507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of a centrally selective cholecystokinin analog on male, Sprague Dawley rats in the non-fasted food intake model.
    Wire WS; Fang SN; Hruby VJ; Finch ST; Kramer TH; Burks TF
    Proc West Pharmacol Soc; 1991; 34():453-9. PubMed ID: 1788328
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholecystokinin and bombesin act independently to decrease food intake in the rat.
    Stein LJ; Woods SC
    Peptides; 1981; 2(4):431-6. PubMed ID: 6276871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement.
    Verbaeys I; León-Tamariz F; Buyse J; De Cuyper M; Pottel H; Van Boven M; Cokelaere M
    Br J Pharmacol; 2007 Oct; 152(3):396-403. PubMed ID: 17618299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of cholecystokinin on central monoaminergic pathways.
    Widerlöv E; Kalivas PW; Lewis MH; Prange AJ; Breese GR
    Regul Pept; 1983 May; 6(2):99-109. PubMed ID: 6308717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive action of cholecystokinin octapeptide on the behavioral effects of L-DOPA in the rat.
    Itoh S; Katsuura G
    Eur J Pharmacol; 1981 Nov; 75(4):313-6. PubMed ID: 6274669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin (CCK-8) elicits prandial sleep in rats.
    Mansbach RS; Lorenz DN
    Physiol Behav; 1983 Feb; 30(2):179-83. PubMed ID: 6302718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cholecystokinin on thyrotropin releasing hormone (TRH)-induced serotonin potentiation in rats.
    Itoh S; Katsuura G
    Jpn J Physiol; 1982; 32(1):145-8. PubMed ID: 6281503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin-induced hypothermia in the rat.
    Katsuura G; Hirota R; Itoh S
    Experientia; 1981 Jan; 37(1):60. PubMed ID: 6258973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of cholecystokinin octapeptide and food intake in male rats treated with cholecystokinin octapeptide.
    Lindén A; Uvnäs-Moberg K; Forsberg G; Bednar I; Södersten P
    J Endocrinol; 1989 Apr; 121(1):59-65. PubMed ID: 2565947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of unilateral intracerebroventricular microinjections of cholecystokinin (CCK) on circling behavior of rats.
    Morency MA; Ross GM; Hesketh D; Mishra RK
    Peptides; 1987; 8(6):989-95. PubMed ID: 3441450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.